Antimicrobial resistance (AMR) represents one of the greatest threats to human and animal health globally. Animal agriculture's contribution to this crisis — through high-volume use of antibiotics that creates selection pressure for resistance — has profound welfare dimensions for both farm animals and humans. But solutions exist: countries that have dramatically reduced livestock antibiotic use have done so without sacrificing productivity or animal health.
Antibiotics work by killing or inhibiting bacteria. Exposure to antibiotics at any dose — therapeutic or sub-therapeutic — creates selection pressure for resistant strains: bacteria with genetic resistance mutations survive while susceptible bacteria are killed. Resistant bacteria then multiply and spread:
The key driver is not whether antibiotics are used, but the volume and conditions of use. Prophylactic group treatment — giving antibiotics to entire groups of animals to prevent disease that may not occur — creates selection pressure without therapeutic benefit for many individuals in the group.
The relationship between intensive farming and antibiotic dependency is not incidental — it is structural. High stocking densities create conditions where disease spreads rapidly; stress from crowding, barren environments, and intensive production suppresses immune function; and pressure for rapid growth creates animals whose physiology is optimized for production rather than disease resistance. Antibiotics have allowed farming systems to be intensified beyond what would be possible if animals had to rely on their own immune systems. In this sense, high antibiotic use is a symptom of welfare-compromised farming systems.
Vaccines prevent specific diseases without creating AMR. Strategic vaccination programs have replaced antibiotic prophylaxis for many common livestock diseases. Investment in new vaccine development for diseases currently treated prophylactically is a high-priority AMR reduction strategy.
Reducing stocking density reduces disease transmission rates and stress-induced immunosuppression. The Danish experience showed that reducing pig density reduced antibiotic use substantially, with minimal production impact. Better designed housing (ventilation, flooring, enrichment) similarly reduces disease burden.
Preventing pathogen introduction through improved biosecurity — strict visitor protocols, hygiene at farm entry, all-in/all-out production management — reduces infection rates without antibiotics.
Emerging alternatives: probiotics (beneficial bacteria) can improve gut health and reduce pathogen colonization; bacteriophages (viruses that kill specific bacteria) offer highly targeted alternatives to broad-spectrum antibiotics. Neither yet replaces antibiotics at scale, but both are being actively developed.
The Netherlands reduced total livestock antibiotic use by over 70% between 2009 and 2020 through mandatory reporting, sectoral targets, and veterinary prescription requirements — without losing market competitiveness. Denmark achieved similar reductions over a similar period. Both countries demonstrate that dramatic AMR reduction in livestock is achievable with appropriate policy and that fears of production loss were overstated. These models provide the template for global action.